Your browser doesn't support javascript.
loading
Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status.
Belkahla, Sana; Haq Khan, Abrar Ul; Gitenay, Delphine; Alexia, Catherine; Gondeau, Claire; Vo, Dang-Nghiem; Orecchioni, Stefania; Talarico, Giovanna; Bertolini, Francesco; Cartron, Guillaume; Hernandez, Javier; Daujat-Chavanieu, Martine; Allende-Vega, Nerea; Gonzalez, Martin Villalba.
Afiliación
  • Belkahla S; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), INSERM, Univ De Montpellier, Montpellier, France.
  • Haq Khan AU; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), INSERM, Univ De Montpellier, Montpellier, France.
  • Gitenay D; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), CHU Montpellier, Montpellier, France.
  • Alexia C; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), INSERM, Univ De Montpellier, Montpellier, France.
  • Gondeau C; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), CHU Montpellier, Montpellier, France.
  • Vo DN; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), INSERM, Univ De Montpellier, Montpellier, France.
  • Orecchioni S; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), CHU Montpellier, Montpellier, France.
  • Talarico G; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), INSERM, Univ De Montpellier, Montpellier, France.
  • Bertolini F; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), CHU Montpellier, Montpellier, France.
  • Cartron G; Département d'Hépato-gastroentérologie A, Hôpital Saint Eloi, CHU Montpellier, Montpellier, France.
  • Hernandez J; Department of Lymphocyte Differentiation, Tolerance and Metabolism: Basis for Immunotherapy, Institut De Médecine Régénératrice Et Biothérapie (IRMB), INSERM, Univ De Montpellier, Montpellier, France.
  • Daujat-Chavanieu M; Department of Oncology and Hemato-Oncology, European Institute of Oncology, Milan, Italy.
  • Allende-Vega N; Department of Oncology and Hemato-Oncology, European Institute of Oncology, Milan, Italy.
  • Gonzalez MV; Department of Oncology and Hemato-Oncology, European Institute of Oncology, Milan, Italy.
Oncotarget ; 9(1): 1114-1129, 2018 Jan 02.
Article en En | MEDLINE | ID: mdl-29416681
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Francia